Variable | Overall survival | Disease-free survival | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Sex | 0.846 | 0.576 | ||
Females | 1 | 1 | ||
Males | 0.96 (0.60–1.52) | 1.14 (0.72–1.79) | ||
Age (years) | <0.001 | <0.001 | ||
≤59 | 1 | 1 | ||
>59 | 2.48 (1.73–3.57) | 1.81 (1.30–2.52) | ||
Tumor location | 0.338 | 0.141 | ||
Upper-thoracic esophagus | 1 | 1 | ||
Middle-thoracic esophagus | 1.51 (0.73–3.13) | 1.72 (0.87–3.41) | 0.119 | |
Lower-thoracic esophagus | 1.20 (0.55–2.60) | 1.30 (0.63–2.70) | 0.479 | |
Tumor size (cm) | 0.291 | 0.276 | ||
<4 | 1 | 1 | ||
≥4 | 1.21 (0.85–1.72) | 1.20 (0.86–1.67) | ||
Pathologic grade | 0.423 | 0.534 | ||
I/II | 1 | 1 | ||
III | 1.17 (0.80–1.69) | 1.12 (0.78–1.59) | ||
TNM stage | <0.001 | <0.001 | ||
I–IIA | 1 | 1 | ||
IIB–IV | 3.16 (2.07–4.83) | 3.24 (2.19–4.80) | ||
T category | 0.018 | 0.051 | ||
1 + 2 | 1 | 1 | ||
3 + 4 | 1.89 (1.12–3.21) | 1.59 (0.99–2.52) | ||
N category | <0.001 | <0.001 | ||
0 | 1 | 1 | ||
1 | 2.97 (1.97–4.47) | 3.12 (2.13–4.57) | ||
HBsAg | 0.199 | 0.802 | ||
Negative | 1 | 1 | ||
Positive | 0.584 (0.26–1.33) | 1.08 (0.58–2.00) | ||
Family historya | 0.486 | 0.271 | ||
No | 1 | 1 | ||
Yes | 0.79 (0.40–1.55) | 0.70 (0.37–1.33) | ||
Glasgow prognostic score | 0.033 | 0.169 | ||
0 | 1 | 1 | ||
1 | 0.99 (0.60–1.62) | 0.951 | 0.89 (0.56–1.43) | 0.633 |
2 | 14.70 (1.95–110.58) | 0.008 | 6.26 (0.86–45.63) | 0.070 |
DA score | <0.001 | <0.001 | ||
0 | 1 | 1 | ||
1 | 2.50 (1.37–4.59) | 0.003 | 1.94 (1.15–3.27) | 0.013 |
2 | 4.12 (2.25–7.54) | <0.001 | 2.99 (1.77–5.08) | <0.001 |